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Edited by M. K. RosenAbstractSignal transduction pathwaysmediated by cyclic-bis(3′ → 5′)-dimeric GMP (c-di-GMP) control many important
and complex behaviors in bacteria. C-di-GMP is synthesized through the action of GGDEF domains that
possess diguanylate cyclase activity and is degraded by EAL or HD-GYP domains with phosphodiesterase
activity. There is mounting evidence that some important c-di-GMP-mediated pathways require protein–
protein interactions between members of the GGDEF, EAL, HD-GYP and PilZ protein domain families. For
example, interactions have been observed between PilZ and the EAL domain from FimX of Xanthomonas citri
(Xac). FimX and PilZ are involved in the regulation of type IV pilus biogenesis via interactions of the latter with
the hexameric PilB ATPase associated with the bacterial inner membrane. Here, we present the crystal
structure of the ternary complex made up of PilZ, the FimX EAL domain (FimXEAL) and c-di-GMP. PilZ
interacts principally with the lobe region and the N-terminal linker helix of the FimXEAL. These interactions
involve a hydrophobic surface made up of amino acids conserved in a non-canonical family of PilZ domains
that lack intrinsic c-di-GMP binding ability and strand complementation that joins β-sheets from both proteins.
Interestingly, the c-di-GMP binds to isolated FimXEAL and to the PilZ–FimXEAL complex in a novel
conformation encountered in c-di-GMP–protein complexes in which one of the two glycosidic bonds is in a
rare syn conformation while the other adopts the more common anti conformation. The structure points to a
means by which c-di-GMP and PilZ binding could be coupled to FimX and PilB conformational states.
© 2013 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
Cyclic-bis(3′ → 5′)-dimeric GMP (c-di-GMP) is a
central signaling molecule that controls complex
physiological processes in bacteria, including
motility,1 biofilm formation,2 cell adhesion,3 quorum
sensing,4,5 cell division and differentiation6,7 and
virulence.8 The synthesis of c-di-GMP through the
condensation of two GTP molecules is catalyzed by
dimeric diguanylate cyclases that contain GGDEF
domains while c-di-GMP hydrolysis is catalyzed by
specific phosphodiesterases (PDEs) that contain
either EAL or HD-GYP domains.9–11 Several classes
of c-di-GMP receptors have been identified, including
enzymatically inactive EAL domains12,13 and inactive0022-2836 © 2013 Elsevier Ltd. Open access under the Elsevier OA liceGGDEF domains,14 allosteric sites (I-sites) on
GGDEF domains,10 PilZ domains,15,16 transcription
regulators of the CAP-like family,17 a non-canonical
receiver domain of the transcriptional regulator VpsT
protein18 and the NtrC family (FleQ),19 as well as c-di-
GMP-dependent riboswitches.20 While it is to be
expected that a minimal c-di-GMP signaling pathway
will consist of at least one active diguanylate cyclase,
one active PDE and one c-di-GMP receptor, most
bacterial genomes code for more than onemember of
each of the above classes, with some genomes
coding for dozens of these proteins.21,22 There is also
mounting evidence that some important c-di-GMP-
mediated pathways require protein–protein interac-
tions betweenmembers of thesedomain families.23–26J. Mol. Biol. (2013) 425, 2174–2197nse.
2175Structure of the PilZ–FimXEAL–c-di-GMP ComplexA major challenge therefore is to understand the
principles by which the large number of c-di-GMP-
associated signaling domains and the even larger
number of possible interactions among them act
together to control complex behaviors in bacteria.
C-di-GMP levels have been shown to regulate
bacterial motility in the majority of bacterial species
in which the relationship has been investigated. For
example, flagellum-dependent swimming is activat-
ed by low c-di-GMP levels in several bacterial
species including Escherichia coli, Salmonella
enterica serovar Typhimurium, Pseudomonas aeru-
ginosa, Pseudomonas fluorescens, Vibrio cholerae,
Vibrio parahaemolyticus, Burkholderia pseudomallei
and Xanthomonas citri.16,18,27–33 In E. coli and
Salmonella, c-di-GMP control of flagella-based
motility involves a physical interaction of a PilZ
domain c-di-GMP receptor protein with components
at the base of the bacterial flagellum.29,30,34
C-di-GMP signaling has also been associated with
the control of bacterial motility dependent on type IV
pili.24,26,35 Type IV pili (T4P) are thin filamentous
structures present on the outer surfaces of many
bacteria. Depending on the particular species, T4P
have been shown to participate in twitching motility
and several other important physiological processes
including adherence to surfaces, pathogenicity,
natural transformation, autoagglutination, chemotax-
is, biofilm formation, immune escape, phage trans-
duction and signal transduction.36–43 T4P filaments
are produced by the secretion and polymerization of
pilin subunits in a process that depends on PilB, a
hexameric ATPase associated with the bacterial
inner membrane, while pilus retraction is powered by
another ATPase, PilT.44–46 The means by which
pilus extension and retraction is controlled is poorly
understood. In P. aeruginosa, two regulators of T4P
biogenesis are PilZ and FimX.47–49 Our group has
recently demonstrated that the X. citri PilZ protein
(PilZ1133) interacts with both PilB and the EAL
domain of FimX.24 Furthermore, in Xanthomonas
campestris pv campestris, the control of motility via
DSF (diffusible signaling factor)-dependent signaling
during quorum sensing is dependent on interactions
between the HD-GYP domain from RpfG and at least
two GGDEF-domain-containing proteins, which in
turn interact with a PilZ-domain-containing protein
that itself interacts with PilT.26
Both PilZ and FimX display unique characteristics
within their respective protein families. The large
family of PilZ homology domains (approximately
4000 sequences in the Pfam database50) pos-
sesses many members that have been shown to
bind c-di-GMP. Canonical PilZ domains display a
closed six-stranded antiparallel β-barrel, the c-di-
GMP binding motif is made up of two basic residues
(normally arginines) in a flexible linker that precedes
the first β-strand and a DxSxxG motif in a loop
between β-strands 2 and 3 and these conservedresidues make specific contacts with functional
groups on the c-di-GMP ligand.16,51–53 However,
the PilZ family is very diverse, and approximately 5%
are expected to adopt an alternative fold typified by
the original PilZ protein from P. aeruginosa, as well
as Xac PilZ1133: the PA2960/XAC1133 orthologous
group.24 This subfamily of PilZ proteins does not
bind c-di-GMP due to a radical change in the N-
terminal secondary structure elements: an inverted
(now parallel) orientation for the first β-strand and the
presence of an α-helix in the loop preceding β2.24,54
These modifications directly disrupt the structural
elements required for ligand binding.
FimX is a member of a large family of proteins that
contain both GGDEF and EAL domains (approxi-
mately 8000 in the Pfam database50). It is expected
that, in most of these proteins, only one of these
domains is enzymatically active, though some
examples are known of proteins in which both or
neither of the domains show or are expected to
possess enzymatic activity.55 FimX belongs to the
latter group of GGDEF-EAL proteins with two
inactive domains but with an EAL domain that
retains the ability to bind c-di-GMP.12,24,49 FimX
proteins from P. aeruginosa and Xanthomonas also
display an N-terminal response regulator receiver
(REC or CheY-like) domain and a PAS domain that
precede the GGDEF-EAL module.12,24,49 The crys-
tal structures of the GGDEF and EAL domains from
P. aeruginosa FimX (29% identical with Xac FimX)
were resolved by Navarro et al.12
The interactions of PilZ with FimX and PilB suggest
ameans bywhich c-di-GMPsignalingmay be directly
coupled to the control of T4P biogenesis.24 In this
report, we describe the crystal structures of the
FimXEAL–c-di-GMP and PilZ–FimXEAL–c-di-GMP
complexes from the citrus pathogen X. citri subspe-
cies citri (Xac). This structure along with that reported
recently by Chin et al.56 are the first high-resolution
structures of a complex between EAL and PilZ
domains and c-di-GMP ligand, and this structure
offers important information about the diverse and
species-dependent manners by which c-di-GMP
could modulate the interactions between regulators
of T4P function.Results
The X-ray crystal structures of the FimX EAL
domain (FimXEAL) and the PilZ–FimXEAL complex,
both with bound c-di-GMP, were determined. Data
collection and refinement statistics are presented in
Table 1. In the following sections, we first describe the
FimXEAL–c-di-GMP structure, with special attention to
the rare conformation observed for the c-di-GMP
ligand. The structure of the PilZ–FimXEAL–c-di-GMP
complex and functional assays are then described.
Table 1. Crystallographic data and refinement statistics
FimXEAL–c-di-GMP FimXEAL–c-di-GMP–Ca
2+ FimXEAL–PilZ–c-di-GMP
Data collection
Space group P21212 P21212 P65
Unit cell parameters
a (Ǻ) 65.7 66.1 126.8
b (Å) 85.5 84.8 126.8
c (Ǻ) 46.3 47.0 107.3
α (°) 90 90 90
β (°) 90 90 90
γ (°) 90 90 120
Resolution range (Ǻ)a 30.00–1.80 (1.86–1.80) 50.00–1.40 (1.45–1.40) 50.00–2.10 (2.18–2.10)
No. of observed reflectionsa 183,903 543,429 601,718
No. of unique reflectionsa 24,851 50,267 57,146
Mean I/σIa 16.56 (3.25) 38.45 (1.93) 25.42 (3.86)
Completeness (%)a 99.8 (99.4) 95.0 (68.0) 99.7 (99.1)
Multiplicitya 7.4 (7.3) 10.8 (4.4) 10.5 (8.5)
Rmerge (%)
a 12.5 (67.4) 5.0 (55.0) 8.3 (58.9)
No. of images 195 538 346
Wavelength (Ǻ) 1.437 1.24 1.459
X-ray beamline D03B-MX1 W01B-MX2 W01B-MX2
Refinement
Resolution range (Ǻ)a 28.34–1.80 (1.85–1.80) 30.00–1.55 (1.59–1.55) 41.50–2.10 (2.15–2.10)
Rfactor/Rfree (%) 15.5/19.8 18.2/23.2 18.7/23.8
r.m.s.d. from ideal geometry
Bond lengths (Ǻ) 0.016 0.015 0.016
Bond angle (°) 1.54 1.543 1.529
Wilson B-factors (Ǻ2) 16.40 18.28 36.4
Refined B-factorsb
Protein (Ǻ2) 18.41 22.39 50.68
Water (Ǻ2) 30.47 36.58 54.92
c-di-GMP (Ǻ2) 12.10 13.51 38.92
GOL (Ǻ2) 44.11 68.86
Ca2+ (Ǻ2) 64.25
Overall (Ǻ2) 19.73 18.28 48.77
Ramachandran plot (%)c
Most favored regions 98.5 99.2 98.9
Allowed regions 1.5 0.8 1.1
Disallowed regions 0 0 0
No. of water molecules 203 303 363
Estimated overall coordinate errord (Ǻ) 0.071 0.060 0.121
PDB code 4FOK 4FOJ 4FOU
Rmerge = (∑|I − 〈I〉|)/∑(I).
Rfactor = ∑|Fo − Fc|/∑|Fo|.
Rfree was calculated using 5% of the reflections selected randomly and omitted from the refinement.
a Values in parentheses refer to the highest-resolution shell.
b Refined B-factors were calculated using the BAVERAGE program in the CCP4i package.94
c Calculated in PROCHECK.100
d Based on maximum likelihood.
2176 Structure of the PilZ–FimXEAL–c-di-GMP ComplexStructure of the X. citri FimX EAL domain in
complex with c-di-GMP
The 689-residue FimX protein from X. citri (coded
by gene XAC2398) is made up of four domains in the
following order: REC, PAS, GGDEF and EAL.24 A
fragment coding for the C-terminal EAL domain
(residues 426–689; FimXEAL) was expressed in E.
coli and purified as described in Materials and
Methods. This fragment is 10 amino acids longer
than the FimXEAL fragment (residues 436–689)
described previously by our group.24 In order to
distinguish the two constructions, we will refer to the
longer fragment as FimXEAL and to the shorterfragment as FimXEAL(436–489). Attempts to crystallize
FimXEAL(436–489) produced crystals that diffracted
poorly. FimXEAL in complex with c-di-GMP crystal-
lized in space group P21212 with one protein
molecule in the asymmetric unit. Initial phases
were calculated by molecular replacement using as
a model the FimX EAL domain from P. aeruginosa
[Protein Data Bank (PDB) ID 3HV8].12 Two crystal-
line structures of the FimXEAL–c-di-GMP complex
with very similar unit cell dimensions were deter-
mined, one in the presence of 0.5 mM CaCl2 that
diffracted to 1.55 Å and one in the absence of Ca2+
that diffracted to 1.8 Å. In spite of the presence of
CaCl2 in the crystallization buffer, no Ca
2+ ions
2177Structure of the PilZ–FimXEAL–c-di-GMP Complexcould be observed in the electron density maps of
the 1.55-Å structure. The two structures are very
similar with a root-mean-square deviation (r.m.s.d.)
of 0.4 Å for Cα atoms. The principal differences
reside in the quality of the electron density maps for
the first 12 residues (426–437) that contribute to
helix α1 and for residues 470 and 471 in the loop
between β1 and β2: while density is observed for
these residues in the structure determined from the
crystal lacking Ca2+, it is absent in the electron
density in the 1.55-Å structure (Supplementary Fig.(b)C
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Fig. 1. Structure of Xac FimXEAL (FimX residues 426–689
FimXEAL. The lobe domain (residues 426–459 and 481–503)
green. In the structure determined to 1.8 Å resolution (shown in
the 1.55-Å structure, no electron density is observed for residue
471 in the loop between β2 and β3. * and ** indicate the positio
The c-di-GMP ligand is shown as a stick model in red. (b)
complexes from Xac (green) and P. aeruginosa (orange; PD
shown. (c) Close-up view of the interactions between the c-di-G
for residues 486–501 of the Xac protein (green) and line models
(orange), apo-FimXEAL (cyan; PDB code 3HV9) and apo-FimXd
for proline residues at the β2b–α2 junction are shown. The c-di-
aeruginosa proteins. Structural alignments in (b) and (c) we
(residues 460–480 and 504–689). (d) Individual views of the c
unwinding of the first turn of the α2 helix in the presence of c-di-
hydrogen bonds. Coloring scheme is the same as in (c).S1). Therefore, unless otherwise stated, we will refer
to the 1.8-Å structure in the discussion below. The
structure, shown in Fig. 1a, presents a modified
triose phosphate isomerase (TIM) barrel topology
β-(β/α)6-β in which the first β-sheet (β1) is antiparallel
with the other seven. β-Strands β1 and β2 extend
from the central β-barrel to join with β2b to form a
small β-sheet that interacts with the C-terminal end
of helix α1 and with helix α2 to form a subdomain
called the “lobe”, a feature observed in other EAL
domain structures.(c)
P491 P490α2
β2b α2
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N492A493
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A496
P Xac FimXEAL-c-di-GMP
) in complex with c-di-GMP. (a) Cartoon representation of
is shown in blue while the TIM barrel domain is shown in
this figure), electron density is available for all residues. In
s 426–434 at the beginning of α1 and for residues 470 and
ns of residues 434 and residues 470 and 471, respectively.
Superposition of stick models of the FimXEAL–c-di-GMP
B code 3HV8). For clarity, only the main-chain atoms are
MP ligands and the β2b–α2 motif, shown as a stick model
for residues 485–500 of P. aeruginosa FimXEAL–c-di-GMP
ual(GGDEF-EAL) (purple; PDB code 3HVB).
12 The side chains
GMP ligands are colored red for the Xac and blue for the P.
re guided by superpositions of the TIM barrel domains
-di-GMP interaction with the β2b–α2 motif highlighting the
GMP. Black broken lines indicate intramolecular backbone
2178 Structure of the PilZ–FimXEAL–c-di-GMP ComplexSize-exclusion chromatography (SEC) (see below)
and diffusion-ordered spectroscopy (DOSY) NMR
analysis (Supplementary Fig. 2) of FimXEAL indicates
that the protein is predominantly monomeric in
solution, both in the presence and in the absence of
c-di-GMP and Ca2+. The diffusion coefficient of
FimXEAL was determined to be 7.49 × 10
11 m2/s
by DOSY NMR analysis, a value consistent with a
predominantly monomeric state.58,59 Furthermore,
analysis of the contacts between EAL domains in
the crystalline lattice using the PISA server60
suggests that none are physiologically relevant. A
monomeric form for Xac FimXEAL is consistent with
the SEC and small-angle X-ray diffraction studies of
Navarro et al.12 for the P. aeruginosa FimXEAL
domain in solution.
Of the EAL domain structures determined to date,
the Xanthomonas FimXEAL domain is most similar to
that of P. aeruginosa FimX (29% sequence identity
for their EAL domains)49 for which there are three
structures available: c-di-GMP-bound (PDB ID
3HV8) and apo (PDB ID 3HV9) structures of the
isolated EAL domain and a second apo structure of
the domain (PDB ID 3HVB) in the context of a FimX
fragment containing both the GGDEF and EAL
domains.12 A superposition of the first two structures
reveals that the most significant conformational
change induced by c-di-GMP binding is an up to
3.7-Å rigid-body movement of the lobe toward the
bound ligand.12 Comparison of the Xac and P.
aeruginosa FimXEAL–c-di-GMP complex with the
apo and c-di-GMP bound forms of the P. aeruginosa
protein shows that the Xac protein adopts a
conformation most similar to that of the P. aerugi-
nosa FimXEAL–c-di-GMP complex (Fig. 1b–d). The
position of the β2b strand in the Xac and P.
aeruginosa FimXEAL–c-di-GMP complexes is shifted
when compared to the position of the β2b strand in
the apo forms of the P. aeruginosa FimXEAL (Fig. 1c).
This shift may in part be explained by contacts
between the c-di-GMP ligand and a conserved
proline residue at the β2b–α2 junction. Notably, in
both FimXEAL–c-di-GMP complexes, the C
β, Cγ and
Cδ methylene groups of the Pro491 (Pro490 in P.
aeruginosa) pyrrolidine ring make an extensive set
of van der Waals contacts with atoms of the ribose,
phosphate and guanosine moieties of one of the
nucleotides of the c-di-GMP ligand (Fig. 1c and d).
This proline residue maintains its N-capping main-
chain (i, i + 4) hydrogen bond even in the c-di-GMP
bound forms (Fig. 1d). However, in order to make
these ligand contacts, the two subsequent main-
chain (i, i + 4) hydrogen bonds (formed between the
backbone carbonyls at positions 492–493 and
amides at positions 496 and 497 in the Xac protein)
are broken, creating a kink in the first turn of helix α2
(Fig. 1d). These proline–c-di-GMP contacts are
highly similar in both FimXEAL–c-di-GMP complexes
in spite of the significantly different conformationsadopted by their c-di-GMP ligands (see below), and
proline is relatively well conserved at this position in
EAL domains in general61 and highly conserved in
the EAL domains of proteins with domain topologies
similar to FimX (Supplementary Fig. 3).
A novel c-di-GMP conformation
The most striking difference between the Xantho-
monas and Pseudomonas FimXEAL–c-di-GMP
structures is the different conformations of the c-di-
GMP moieties. In P. aeruginosa FimX, both guanine
bases are in the anti conformation as defined by the
orientation of the N-glycosidic bond. In contrast, the
c-di-GMP molecule bound to Xac FimXEAL has one
guanine base in the anti orientation (Ganti) while the
other is in a syn orientation (Gsyn) (Fig. 2a and
Supplementary Fig. 4). The Xac FimXEAL binding
pocket that accommodates the Ganti base is made up
of residues derived from both the TIM barrel (A478,
F479, L480, D508 and R534) and the lobe (P491
and M495) (Fig. 2b). This binding pocket is similar to
that observed in other EAL–c-di-GMP complexes.
The binding pocket that accommodates the Gsyn
base is largely devoid of solvent molecules and is
made up of residues that are derived from the Xac
FimXEAL TIM barrel: Q463, F479, R534, E653, F654,
Q673, G674 and D675 (Fig. 2b). These interactions
include hydrogen bonds between the guanine base
and the E653 and Q673 side chains and the Q673
main-chain NH group (Fig. 2b and Supplementary
Fig. 4a). The syn conformation is further stabilized by
a hydrogen bond between the N2 amino group of the
guanine base and the O11 atom of the c-di-GMP
phosphate group (Fig. 2b). Interestingly, a simple
~135° rotation about the C1′–N9 glycosidic bond
can place the syn guanine base in an anti orientation
that fits snugly into a 7-Å-wide gap between the F654
and D675 side chains (Fig. 2c) with only one bad
steric contact (2.2 Å between the guanine O6 atom
and the G674 Cα atom of the protein) that can be
easily alleviated by very small adjustments in the
protein or ligand (data not shown). The gap between
residues F654 and D675 corresponds to a similar
gap between residues F652 and Y673 that accom-
modates this guanine base in the anti conformation
in the P. aeruginosa FimXEAL–c-di-GMP complex
12
(Fig. 2d). Therefore, the possibility exists that c-di-
GMP could also bind to FimXEAL in the “canonical”
all-anti conformation under some conditions. A
different all-anti conformation was reported for c-di-
GMP bound to the FimXEAL–PilZ complex from X.
campestris strain 1756 (see Discussion for an
analysis of that structure).
To date, two enzymatically active EAL domains
have been crystallized in complex with c-di-GMP:
BlrP1 from Klebsiella pneumoniae (PDB accession
code 3GG0)62 and TBD1265 from Thiobacillus
denitrificans (PDB code 3N3T).63 In these active
Fig. 2. A novel conformation of the c-di-GMP ligand. (a) Comparison of the c-di-GMP conformation in Xac FimXEAL with
its conformation in other EAL–c-di-GMP complexes. The c-di-GMP molecule bound to Xac FimXEAL is shown as a stick
model in red. C-di-GMP molecules as they are observed bound to P. aeruginosa FimX (PDB ID 3HV8; magenta),12 P.
fluorescens LapD (PDB ID 3PJT; black),13 TBD1265 from T. denitrificans (PDB ID 3N3T; cyan),63 BlrP1 from K.
pneumoniae (PDB ID 3GG0; green)62 and YkuI from B. subtilis (PDB ID 2W27; orange).64 A 5′-pGpGmolecule is shown in
the conformation when bound to an EAL domain from C. crescentus (blue; PDB ID 3U2E). C-di-GMP molecules are
superposed based on the superposition of their respective EAL domains that have been omitted from the figure for clarity.
(b) FimXEAL–c-di-GMP contacts. The c-di-GMP molecule is shown in red and contacting FimXEAL residues are shown in
cyan (for atoms within 4 Å of the c-di-GMP molecule) and green. The broken line represents a hydrogen bond of the N2
amino group of the guanine base with the O11 atom of the c-di-GMP phosphate group. Arrowheads point to the guanidino
groups of the R481 and R534 side chains that make ionic bonds with the negatively charged phosphate groups from c-di-
GMP. (c) Stick model of the c-di-GMP ligand (red) bound to the surface of FimXEAL. The FimXEAL surface is colored green
or blue for residues that come within 5 Å of the Gsyn base. A simple ~135° rotation about the C1′–N9 glycosidic bond can
place the syn guanine base in an anti orientation (yellow) that fits snugly into a 7-Å-wide gap between the F654 and D675
side chains with only one bad steric contact (2.2 Å between the guanine O6 atom and the glycine 674 Cα atom of the
protein) that can be alleviated by very small adjustments in the protein or ligand. (d) Stick model of c-di-GMP (yellow)
bound to the surface of the EAL domain of FimX from P. aeruginosa using the same coloring scheme as in (c). P.
aeruginosa FimX residues F652, G672 and Y673 occupy positions that correspond to F654, G674 and D675 from Xac
FimX.
2179Structure of the PilZ–FimXEAL–c-di-GMP Complexenzymes, two divalent metal ions at the protein–c-di-
GMP interface are separated by a bridging water
molecule that is activated for nucleophilic attack on
the phosphate group of the substrate (Fig. 3a and
Supplementary Fig. 5). The structures of three
enzymatically inactive EAL domains with c-di-GMP
bound have also been determined: YkuI from
Bacillus subtilis (PDB code 2W27),64 P. aeruginosa
FimX (PDB code 3HV8)12 and LapD (PDB code
3PJT).13 These inactive EAL domains present
substitutions in one or more highly conserved
residues necessary for metal ion coordination
(Supplementary Fig. 5c). In spite of these sub-
stitutions, the c-di-GMP ligands have both guanine
bases in the anti orientation in all five of the
abovementioned structures (Fig. 2a). Furthermore,
a 5′-pGpG molecule (the hydrolysis product of c-di-
GMP) adopts a similar conformation when bound toan EAL domain from Caulobacter crescentus (PDB
code 3U2E; unpublished) (Fig. 2a). There is,
however, a certain degree of heterogeneity in the
values of the 12 backbone torsion angles of the
sugar-phosphate macrocycle in EAL domain–c-di-
GMP complexes. Figure 3b compares the macro-
cycle conformations of c-di-GMP bound to Xac
FimXEAL, P. aeruginosa FimXEAL and the enzymat-
ically active EAL domain from TBD1265 protein from
T. denitrificans. Supplementary Table 1 compares
the torsion angles observed in six EAL domain–c-di-
GMP complexes determined to date. Notably,
significant variation is observed for seven of the
twelve macrocycle angles (α1, β1, γ1, α2, γ2, ε2, ζ2)
with the greatest variability observed for α1 and β1.
There is no clear correlation of the values of these
macrocycle bond angles with the conformation of the
glycosidic bond. However, five of these bond angles
Fig. 3. (a) Comparison of the hydrogen bonding networks the TBD1265–c-di-GMP (left) and Xac FimX–c-di-GMP (right)
complexes. In the TBD1265–c-di-GMP complex (PDB code 3N3T63), two Mg2+ ions (small spheres) that activate a
nucleophilic water molecule (star) are coordinated by Asn584, Asp 646 and Glu703 side chains (see Supplementary Fig.
5a for the full set of interactions). In the FimX–c-di-GMP complex, the corresponding positions are occupied by residues
Arg534, Glu596 and Glu653, which drastically changes the nature of the interactions with the c-di-GMP ligand. The
guanidino group of the R534 side chain makes two sets of bidentate hydrogen bonds, one with the phosphate group 5′ to
the syn guanosine and one with the carboxylate group from the Glu596 side chain. This highly stable hydrogen bonding
network has the effect of pushing the c-di-GMPmacrocycle down from its normal position and inducing modifications in the
sugar-phosphate torsion angles. The syn conformation is further stabilized via the formation of the hydrogen bond between
the N2 amino group of the guanine base and the O11 atom of the c-di-GMP phosphate group. (b) Top left: Relative
conformations of c-di-GMP molecules bound to Xac FimXEAL (salmon), P. aeruginosa (P.a.) FimXEAL (blue) and TBD1265
(cyan). Here, the c-di-GMP molecules were superimposed based on the similar conformations of the torsion angles
labeled in black. Significant differences are observed for the torsion angles labeled in red. Approximate values of these
torsion angles are indicated in the table. See Supplementary Table 1 for a full set of torsion angles.
2180 Structure of the PilZ–FimXEAL–c-di-GMP Complex(α1, β1, γ1, ε2, ζ2) flank the phosphate group that
suffers nucleophilic attack in EAL domains with PDE
activity (Fig. 3b) and we do in fact observe that all
twelve bond angles are very similar in the c-di-GMP
molecules bound to the two enzymatically active
EAL domains (BlrP1 and TBD1265) (Supplementary
Table 1). It is to be expected that the maintenance of
PDE activity would impose strict restrictions on the
conformation of substrate binding.
In solution, c-di-GMP shows a remarkable structural
polymorphism in which the interconversion between
monomeric, dimeric, tetrameric and octameric forms is
strongly dependent on concentration and cationspecies.65–68 Solution NMR studies have provided
evidence that the tetrameric and octameric species
can exist in all-syn and all-anti conformations.68
Monomeric c-di-GMP in solution is presumably in
a fast conformational equilibrium between multiple
forms that includes both syn and anti species.69,70
In contrast, in all of its small molecule crystalline
forms, c-di-GMP is observed as an intercalated
dimer with glycosidic bonds solely in the anti
conformation. 71–73 In protein–c-di-GMP com-
plexes, the dinucleotide has been found as a
monomer, dimer or tetramer. In all previously
determined EAL–c-di-GMP, GGDEF–c-di-GMP
2181Structure of the PilZ–FimXEAL–c-di-GMP Complexand PilZ–c-di-GMP complexes, as well as in
riboswitch–c-di-GMP complexes, both glycosidic
bonds are in the anti conformation (e.g., see Refs.
12–14, 18, 51, 62, 64 and 74–77). The present work
and that of the group of Chin et al. published during
the preparation of this work56 are therefore the first
observations of the syn orientation for an N-
glycosidic bond in protein-bound c-di-GMP.
The above observations bring up the question as
how to explain the radically different conformation
adopted by c-di-GMP when bound to Xac FimXEAL
when it would seem that steric considerations alone
do not disallow the anti conformation (see above). As
well as specific contacts with the guanine bases, Xac
FimXEAL also makes specific contacts with the
sugar-phosphate macrocycle, including salt bridges
between the positively charged guanidino groups
from the R481 and R534 side chains and the two
phosphate groups from c-di-GMP (Figs. 2b and 3a).
The salt bridge involving R481 and the phosphate
group 3′ to the syn guanosine is observed in all other
EAL–c-di-GMP complexes (Supplementary Fig. 5a
and b), and arginine is highly conserved at this
position in the EAL domain family.61 On the other
hand, the position occupied by Arg534 in Xac FimX
is most often an asparagine residue in enzymatically
active EAL domains where it participates in the
coordination of one of the metal ions at the active site
(Fig. 3a and Supplementary Fig. 5).62,63 In the Xac
FimXEAL–c-di-GMP structure, the guanidino group of
the Arg534 side chain makes two sets of bidentate
hydrogen bonds, one with the phosphate group 5′ to
the syn guanosine and one with the carboxylate
group from the Glu596 side chain (Fig. 3a). This
highly stable hydrogen bonding network involving
the sterically bulky Arg534 side chain has the effect
of pushing the c-di-GMP macrocycle down from its
normal position and inducing modifications in the
sugar-phosphate torsion angles. The syn conforma-
tion is further stabilized via the formation of the
hydrogen bond between the N2 amino group of the
guanine base and the O11 atom of the c-di-GMP
phosphate group and by specific hydrogen bonds
and van der Waals interactions with the protein
described above (Figs. 2b and 3a and Supplemen-
tary Fig. 4a).Structure of the PilZ–FimXEAL–c-di-GMP
complex
The PilZ–FimXEAL–c-di-GMP complex crystallized
in space group P65 and diffracted to 2.1 Å (Table 1).
Initial phases were determined by molecular re-
placement using the structures of the PilZ24 and
FimXEAL subunits as templates. The asymmetric unit
contains two PilZ molecules and two FimXEAL
domains, and the subunit organization of the
asymmetric unit can be best described as a non-symmetrical dimer of highly similar PilZ–FimXEAL
heterodimers (chains AC and chains BD; Supple-
mentary Fig. 6a). The structure of one of the PilZ–
FimXEAL heterodimers with c-di-GMP bound is
shown in Fig. 4a. One c-di-GMP molecule is bound
to each of the FimXEAL domains, and the c-di-GMP
conformation is almost identical with that observed in
the FimXEAL–c-di-GMP complex (r.m.s.d. equal to
0.13 Å; see Supplementary Fig. 7 for omit maps of
the c-di-GMP binding sites in both FimXEAL–c-di-
GMP and PilZ–FimXEAL–c-di-GMP complexes). The
conformations of the PilZ and FimXEAL subunits in
the complex are very similar to the structures of the
subunits on their own24 with r.m.s.d. values of
0.65 Å and 0.90 Å for Cα positions in PilZ and
FimXEAL, respectively. Structural alignment of the
two PilZ proteins in the asymmetric unit shows that
they are very similar with an r.m.s.d. of 0.58 Å for Cα
atoms. More significant differences can be observed
in the comparison of the two FimXEAL domains of the
asymmetric unit (r.m.s.d. of 0.73 Å for Cα atoms).
One difference is in the conformation of the loop
between helix α1 and strand β1 of FimXEAL made up
of residues 453–457 (sequence Leu-Val-Gly-Asp-
Gly). While the electron density is very clear and the
conformation is well defined for this loop in chain B,
in chain A, the electron density map clearly indicates
multiple conformations. We therefore modeled two
conformations for this loop, one of which corre-
sponds to the conformation found in chain B
(Supplementary Fig. 8). Differences in crystal lattice
contacts of the two EAL domains may explain these
different conformations. In the case of chain A, the
loop makes contacts with the solvent-exposed and
highly charged surface of helix α10 of a symmetry-
related FimXEAL chain A. On the other hand, the
same loop in chain B makes no significant contacts
with symmetry-related molecules in the crystal
lattice. Other structural differences between the two
heterodimers are discussed below.
The PilZ–FimXEAL interfaces within the hetero-
dimers defined above bury 1533 Å2 and 1784 Å2 of
surface area for the AC and BD FimXEAL–PilZ chain
pairs, respectively. The residues found at the
interfaces within both heterodimers are listed in
Supplementary Table 2 and shown in Fig. 4c. FimX
residues involved in the interface are located in the
lobe subdomain (Fig. 4c), the only exceptions being
P679, T680, G681 and P682 from the extended coil
region at the C-terminus of the TIM barrel domain
that are observed to make tenuous contacts with the
β3–β4 loop of PilZ in only one of the two hetero-
dimers (Supplementary Table 2). While the PilZ
residues at the interface correspond very closely to
highly conserved residues in the PA2960/XAC1133
orthologous group,24 FimX residues at the interface
are not very well conserved in the FimX homologs
with similar domain architectures (Fig. 4c and d and
Supplementary Table 2).
Fig. 4. The PilZ–FimXEAL–c-di-GMP complex. Cartoon (a) and surface (b) representations of the complex. PilZ is
shown in yellow and FimXEAL is shown in green. The c-di-GMP ligand (stick representation shown in red) adopts an syn/
anti conformation almost exactly the same as that observed in the FimXEAL–c-di-GMP complex. The secondary structure
elements of PilZ and the FimXEAL lobe are labeled to highlight the extended β-sheet consisting of strands β1-β2-β2b from
the FimXEAL lobe and β5-β6-β3-β2 from PilZ. (c) Residues at the PilZ–FimX interface in the complex. The surfaces of
atoms that come within 4 Å of an atom from other polypeptide are colored brown for PilZ and dark green for FimXEAL.
Specific residues involved in this interface are labeled. (d) Conserved residues in the PA2960/XAC1133 PilZ orthologous
group as described in Guzzo et al.24 and in the 69 closest homologs of FimX using the same coloring scheme as in (c).
Comparing (c) and (d) reveals that many of the conserved positions in PilZ are found at the interface while positions
conserved in the FimX EAL domain are not found at the interface.
2182 Structure of the PilZ–FimXEAL–c-di-GMP ComplexPilZ–FimXEAL contacts can be divided into three
main groups based on the conserved PA2960/
XAC1133 orthologous group motifs24 involved in
the interaction. One group of contacts involves
residues derived from PilZ motif II and the β2b–α2
motif in the FimXEAL lobe that undergoes a confor-
mational change upon c-di-GMP binding in P.
aeruginosa FimX12 (see above and Fig. 1d). Spe-
cifically, the acidic side chain of FimXEAL Glu487
simultaneously hydrogen bonds to the Oγ hydroxyl
group of Thr71 and to the Nε-H group of the Trp69
indole ring in PilZ (Fig. 5a and Supplementary Fig.
9a). PilZ Trp69 adopts two rotamer conformations
(due to an ~45° rotation about the Cβ–Cγ bond) in
both of the PilZ chains of the asymmetric unit. In one
of these conformers, the indole ring contacts the side
chains of FimX Met489 and Ala493 as well asTrp445 (and Arg484 in one of the heterodimers).
Both conformers make a hydrogen bond via Nε1 and
the Glu487 carboxylate. The side chain of its
neighboring residue, Ile68, also contacts the side
chains of FimX Ser490, Asn492 and Ala493 (Fig. 5c
and Supplementary Fig. 9a). Interestingly, Asn492
and Ala493 correspond precisely to the residues in
the first turn of P. aeruginosa FimXEAL helix α2
whose backbone hydrogen bonds are broken upon
c-di-GMP binding12 as described above (Fig. 1d).
The hydrogen bonding requirements are satisfied in
the complex via two or three ordered water
molecules that bridge the PilZ–FimXEAL interface
and by the correctly oriented backbone amide of PilZ
Lys30 (Supplementary Fig. 9b).
A second group of contacts at the interface involves
the first half of PA2960/XAC1133 PilZ orthologous
Fig. 5. Details of specific PilZ–FimXEAL contacts involving conserved PA2960/XAC1133 PilZ orthologous group
motifs.24 (a) Contacts between residues derived from PilZ motifs I and II and the β2b–α2 motif in the FimXEAL lobe.
Hydrogen bonds between main-chain groups of PilZ β5 and FimXEAL β2b and between specific side chains are shown as
black broken lines. (b) Contacts between the first half of PA2960/XAC1133 PilZ orthologous group conserved motif I and
helices α1 and α2 of the FimXEAL lobe. In the chain A/C heterodimer, the PilZ Phe28 side chain adopts a single rotamer
conformation shown as a yellow stick, while in the B/D heterodimer, Phe28 is found in two conformations, one similar to
that described above and the other (shown in orange) rotated approximately 90° toward FimXEAL α2, making contacts with
Trp445, Ala493 and Ile496. (c) Conserved PilZ Tyr22 fits into a pocket formed by the side chains of residues Tyr429,
Ala434 and Arg441 at the N-terminus of FimXEAL helix α1. PilZ Leu104, a highly conserved residue in the C-terminal α2
helix of PilZ (and part of conserved motif IV24), contacts FimX Tyr429 (black broken line). (d) Interactions of conserved PilZ
residues Leu44 and Gly45 with the c-di-GMP ligand bound to FimXEAL. The broken line shows the 3.4-Å hydrogen bond
observed between the Leu44 backbone carbonyl and the 2′ hydroxyl group of the Gsyn nucleotide of the c-di-GMP
molecule. Furthermore, the Cα atom of PilZ Gly45 comes within 4.5 Å of the O2′, O4′, C4′ and O3′ atoms of the Gsyn
nucleotide. The contacts shown are observed in the heterodimer made up of chains A and C of the asymmetric unit. In the
chain B and D heterodimer, these distances increase to between 5.8 and 6.8 Å. The PilZ Val67 carbonyl oxygen interacts
with the c-di-GMP phosphate group via a bridging water molecule.
2183Structure of the PilZ–FimXEAL–c-di-GMP Complexgroup conserved motif I, beginning at helix α2 and
extending to the loop between β2 and β3. The most
conserved PilZ residues at this interface are Tyr22,
Pro27 and Phe28. The Phe28 side chain adopts
different conformations in the two PilZ–FimXEAL
heterodimers. In the heterodimer made up of chains
A and C, Phe28 adopts a single conformer that places
its side chain into a hydrophobic pocket at the corner
at which FimXEAL helices α1 and α2 cross each other
perpendicularly, making contacts with residues
Glu438, Arg441, Ile442, Trp445 and Ile487 (Fig. 5b).
In the chain B/D heterodimer, PilZ Phe28 is found intwo conformations, one similar to that described
above and the other one rotated approximately 90°
toward FimXEAL α2, making contacts with Trp445,
Ala493 and Ile496. Interestingly, this second con-
former of Phe28makes an intramolecular contact with
the indole ring of Trp69, which also adopts two
conformations, as mentioned above (Fig. 5b). This
brings up the possibility that the aromatic side chains
of Phe28 and Trp69 may undergo coordinated
motions. Conserved PilZ Tyr22 fits into a pocket
formed by the side chains of residues Tyr429, Ala434
and Arg441 at the N-terminus of FimXEAL helix α1
2184 Structure of the PilZ–FimXEAL–c-di-GMP Complex(Fig. 5b and c). Furthermore, Leu104, a highly
conserved residue in the C-terminal α2 helix of PilZ
(and part of conserved motif IV24), also makes side-
chain–side-chain contacts with Tyr429 and a hydro-
gen bond between the Tyr429 side-chain hydroxyl
and the main-chain carbonyl of Leu104 (Fig. 5c).
Other residues involved in this interface include
conserved PilZ Pro27 that contacts FimXEAL Arg441
and a salt bridge formed by the side chains of PilZ
Lys30 and FimXEAL Glu499 (Fig. 5b and c). These
interactions appear to affect the conformation of the
FimXEAL N-terminal helix. In the absence of PilZ, helix
α1 of FimXEAL has a pronounced curvature (Fig. 1a
and Supplementary Fig. 10). This curvature is
eliminated in one of the PilZ–FimXEAL heterodimers
(chain B) and is inverted in the other (chain A;
Supplementary Fig. 10). This change in curvature
results in an ever-increasing difference in the atomic
positions as onegoes toward theN-terminal end of the
α1 helix, and at Pro431, this difference is between
7.0 Å and 9.4 Å (Supplementary Fig. 10). Since
FimXEAL helix α1 can be considered a linker helix
between the EAL and the preceding GGDEF domain,
the orientation between these two domains may be
controlled via interactions with PilZ residues Tyr22,
Pro27, Phe28 and Leu104.
Another group of intermolecular interactions is
located in the interface of FimXEAL, the c-di-GMP
ligand and the conserved residues Leu44 and Gly45
located in the loop between β3 and β4 from PilZ. The
PilZ Leu44 side chain makes contact with FimXEAL
Arg481 and Met488. A significant observation is that,
in one of the heterodimers (chains A and C), the
Leu44 backbone carbonyl makes a 3.4-Å hydrogen
bond with the 2′ hydroxyl group of the Gsyn
nucleotide of the c-di-GMP molecule. Furthermore,
the Cα of the absolutely conserved Gly45 from PilZ
comes within 4.5 Å of the O2′, O4′, C4′ and O3′drawings (lime green bound to chain A and dark purple bound
FimXEAL (for clarity, the rest of the FimXEAL domain has been o
part due to a relative rotation about an axis approximately pa
β3-β6-β5 and to the FimXEAL α1 helix. Distances between equ
residues in α1, β2 and α2 of PilZ and in α1 of FimXEAL. The
approximately 90°.atoms of the Gsyn nucleotide (Fig. 5d). In the other
heterodimer, these distances increase to between
5.8 and 6.8 Å. Furthermore, the backbone carbonyl
oxygen of PilZ Val67 interacts with the phosphate
group of c-di-GMP via a water bridge (Fig. 5d). While
these PilZ–c-di-GMP contacts can be considered
tenuous, it is significant that substitution of Gly45 for
any other amino acid (other than perhaps alanine)
would sterically inhibit the simultaneous binding of c-
di-GMP and PilZ, which may explain the absolute
conservation of glycine at this position within the
PA2960/XAC1133 orthologous group.24 During the
preparation of this work, Chin et al. showed that a
Gly → Ala substitution at this position in Xcc PilZ
abolishes its interaction with the Xcc FimX EAL
domain in the presence of c-di-GMP.56
As mentioned above, the conformations and
relative orientations of the two polypeptides in the
two heterodimers of the asymmetric unit are very
similar. However, if only the TIM barrels of the two
EAL domains are used to orient a superposition of
the two heterodimers, a shift in the relative orienta-
tions of the EAL lobes and PilZ proteins becomes
evident (Fig. 6) with an r.m.s.d. of 2.6 Å for the main-
chain atoms of the PilZ proteins. In spite of this shift,
most of the PilZ–FimXEAL contacts observed above
are maintained in the two heterodimers (in part, due
to compensatory shifts in the positions of the
FimXEAL α1 helix; Supplementary Fig. 10), one
exception being the direct contact between PilZ
and the c-di-GMP ligand that is observed only in one
of the heterodimers.
Evidence for a physiologically relevant
PilZ–FimXEAL heterodimer
Several lines of evidence are consistent with the
heterodimer described above as being the predom-Fig. 6. Superposition of the two
PilZ–FimXEAL heterodimers ob-
served in the asymmetric unit. (a)
The structural alignment was based
on the superposition of the FimXEAL
TIM barrel domains, which reveals
small but significant shifts in the
positions of PilZ and of the N-
terminal helix α1 of FimXEAL. For
clarity, only the Cα atoms of FimX-
EAL chains A (green) and B (red)
and PilZ chains C (dark green) and
D (magenta) are shown. The c-di-
GMP molecules are shown as stick
to chain B). (b) View from the C-terminal end of helix α1 of
mitted). The difference in positions of the PilZ domains is in
rallel with the plane of the β-sheet formed by PilZ strands
ivalent Cα atoms in the two heterodimers are indicated for
orientations in (a) and (b) are associated by a rotation of
2185Structure of the PilZ–FimXEAL–c-di-GMP Complexinant form in solution. Firstly, an analysis of the
protein–protein contacts in the crystal lattice60 in-
dicates that the only interfaces of potential physio-
logical relevance are those observed between the
PilZ monomers and FimXEAL monomers in the two
heterodimers of the asymmetric unit. The EAL–EAL
and PilZ–PilZ contacts observed in the crystal lattice
(Supplementary Fig. 6) have low complexation
significance scores and are therefore probably not
physiologically significant. The only interfaces with
high complexation significance scores (CSS = 1.0)
are those between FimXEAL chain A and PilZ chain C
and between FimXEAL chain B and PilZ chain D.(a)
(c)
(e)
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Fig. 7. SEC analysis of the PilZ–FimXEAL complex. (a) SEC
and the PilZ–FimXEAL complex at different concentrations (40
black continuous line). Free PilZ and free FimXEAL elute as mo
36.3 kDa, respectively, which correspond well with the theo
complex applied at the above concentrations elutes with
respectively, close to the value of 42.1 kDa expected for a
markers are indicated: (a–e) 200, 150, 66, 29 and 12.4 kDa, res
used in place of FimXEAL. Free FimXEAL(436–489) elutes with
calculated mass of 28.6 kDa. When applied at 40, 60 and 80 μM
mass of 41 kDa) elutes with an apparent mass of 44.8, 53
complexes were not observed when wild-type FimXEAL was sub
Complex formation was also abolished when wild-type PilZ w
formed with the E101A mutant (f). In all of the above experimen
GMP (data not shown). In all cases, a 2:1 PilZ-to-FimXEAL m
FimXEAL). To facilitate comparison, we normalized the heights o
times.DOSY NMR analysis of the complex indicates that
the predominant species in solution is a 1:1 PilZ–
FimXEAL complex (Supplementary Fig. 2). We also
estimated the size of the PilZ–FimXEAL complex by
SEC analysis using a calibrated Superdex 75
column (Fig. 7a). We observed formation of a 1:1
PilZ–FimXEAL complex both in the absence and in
the presence of c-di-GMP (Fig. 7a and data not
shown). The estimated molecular mass of the PilZ–
FimXEAL complex (theoretical molecular mass =
42.1 kDa) using SEC was observed to increase
from 40 to 45 kDa as the protein concentration of the
sample injected into the column was increased from(b)
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2186 Structure of the PilZ–FimXEAL–c-di-GMP Complex40 μM to 80 μM (Fig. 7a). This indicates that a small
amount of higher-order oligomers could be in fast
exchange with the heterodimer.
During the preparation of this work, Chin et al.
reported the structure of the PilZ–FimXEAL–c-di-GMP
complex from Xcc strain 17.56 A detailed comparison
of the two structures is presented inDiscussion below,
but two significant differences are as follows: (i) the
Xcc strain 17 PilZ–FimXEAL complex was only
observed to form in the presence of c-di-GMP, and
(ii) it elutes with an estimated molecular mass of
94.5 kDa in SEC analysis, indicative of the formation
of a (PilZ)2–(FimX)2 tetramer.
56 Since the reported
Xcc strain 17 complex used a FimXEAL domain that
lacks the first 10 (426–435) and the last 5 (685–689)
residues ofXacFimXEAL in the structures presented in
this work, we repeated the SEC analyses using the
Xac FimXEAL(436–489) construct,
24 which is also 10
residues shorter at its N-terminus and therefore
corresponds more closely to the construct used by
Chin et al. On its own, FimXEAL(436–489) (theoretical
mass = 28.6 kDa) elutes with an apparent molecular
mass of 34.4 kDa (Fig. 7b). As expected, this is
slightly less than the apparent molecular mass of
36.3 kDa observed for FimXEAL (theoretical mass =
29.7 kDa) (Fig. 7a). As with the PilZ–FimXEAL
complex, we observed that the PilZ–FimXEAL(436–489)
complex (theoretical molecular mass of 41 kDa)
elutes with an apparent mass that is dependent
on the concentrations of the proteins. When 40 μM
complex is used, its elution volume corresponds to
an apparent molecular mass of 44.7 kDa, which
increases to 53.8 kDa and 61.1 kDa when the
protein concentration is increased to 60 μM and
80 μM, respectively (Fig. 7b). Interestingly, Xac
PilZ–FimXEAL(436–489) complex formation was also
observed to form both in the absence (Fig. 7b) and
in the presence (data not shown) of c-di-GMP.
These results are consistent with those recently
published by Qi et al. who observed complex
formation between Xac PilZ and a Xac FimXEAL
construct very similar to FimXEAL(436–689).
78 Possible
reasons for the different behaviors of Xac and Xcc
strain 17 PilZ–FimXEAL complexes are presented in
the Discussion.
Finally, we used a set of PilZ and FimXEAL mutants
to test the importance of specific residues and c-di-
GMP for the formation of the PilZ–FimXEAL complex.
The PilZ mutants PilZY22A, PilZF28A, PilZW69A and
PilZE101A all have modifications in residues con-
served in the family of PilZ orthologs,24 the first three
of which are found at the PilZ–FimXEAL interface
(Fig. 5 and Supplementary Fig. 9). Two FimXEAL
mutants were produced: FimXEAL_R534A modifies a
residue directly involved in c-di-GMP binding
(Fig. 2b) and FimXEAL_N493A modifies a residue at
the PilZ–FimXEAL interface and whose conformation
could change in response to c-di-GMP binding
(Fig. 1d). The stability of the N493A mutant wasshown to be reduced in thermal denaturation
experiments monitored by circular dichroism
(reflected by a 3 °C reduction in denaturation
temperature) while the stability of the R534A mutant
was very similar to that of the wild-type FimXEAL
(Supplementary Fig. 11). The addition of c-di-GMP
increased the thermal stability of wild-type FimXEAL
and the A493N mutant by 10 °C and 8 °C,
respectively (Supplementary Fig. 11). However,
the shift observed for the R534A mutant was less
than 2 °C, indicating that c-di-GMP binding by this
mutant was significantly reduced, as expected
(Supplementary Fig. 11). We then used SEC to
test the stability of reconstituted PilZ–FimXEAL
complexes containing these mutants. Some elution
profiles are shown in Fig. 7c–f. While the PilZY22A,
PilZW69A (data not shown) and PilZE101A (Fig. 7f)
mutants are able to form a complex with FimXEAL,
the PilZF28A mutant fails to form a complex with
FimXEAL (Fig. 7e). Furthermore, both FimXEAL_A493N
and FimXEAL_R534A mutants fail to form a complex
with wild-type PilZ (Fig. 7c and d). As mentioned
above, conserved Phe28 of PilZ interacts with
several FimXEAL residues including Ala493 (Fig. 5a
and b). The same results were observed both in the
absence of c-di-GMP and when 150 μM c-di-GMP
was added to the mixtures prior to injection into the
SEC column (data not shown). Since the Tyr22 and
Trp69 mutants continue to interact, we conclude that
the complex is maintained by other interactions that
are not perturbed by these mutations. As mentioned
above, the Trp69 side chain adopts two rotamer
conformations in the complex and only one of these
conformers makes extensive direct contacts with
FimXEAL (Fig. 5a and b).
Ca2+-mediated heterodimer–heterodimer
contacts in the crystal lattice
The two PilZ–FimXEAL heterodimers in the asym-
metric unit contact one another via two separate
interfaces. One is formed exclusively through con-
tacts between helices α3 and α5 from the barrel
domain of one FimXEAL (chain B) and helices α6 and
α8 from the barrel domain of the other FimXEAL
(chain A). The second interface is made up of where
the N-terminal α1 helices from both FimXEAL chains
and the C-terminal α2 helix from one PilZ chain (C)
come together. The PilZ–FimXEAL–c-di-GMP com-
plex was crystallized in the presence of 200 mM
CaCl2, and two of the three Ca
2+ ions modeled in the
electron density are found at this second interface
(Supplementary Fig. 12). All the coordination posi-
tions in both Ca2+ ions are occupied by oxygen
atoms from either water or acidic amino acid side
chains. One of the Ca2+ ions is coordinated in a
pentagonal bipyramidal manner by Glu440 and
Glu443 side chains from FimXEAL chain B plus five
water molecules. The second Ca2+ is coordinated,
2187Structure of the PilZ–FimXEAL–c-di-GMP Complexin a configuration that can be described as a
distorted octahedron, by oxygens from the Glu440
side chain of FimXEAL chain B, the Asp435 side
chain from FimXEAL chain A and four water
molecules. The Ca2+ ions are separated by 5.7 Å
and bridged by the Glu440 carboxylate group from
chain B. Seven of the nine coordinating water
molecules also make hydrogen bonds with side-
chain carboxylates or main-chain carbonyl groups of
FimXEAL residues Glu438 from chain A, Arg436,
Glu439 and Glu443 from chain B and PilZ residues
Glu101 and Pro27 from chain C (Supplementary Fig.
12). A third Ca2+ is found to be coordinated by side-
chain and main-chain oxygen atoms from residue
Asp502 and a bidentate interaction with the side-
chain carboxylate group of E506 located in the short
bend between α2 and α3 and the first turn of α3 from
only one of the two FimXEAL molecules in the
asymmetric unit (chain A). The above observations
raised the possibility that the two Ca2+ ions bridging
the N-terminal helices of the two FimXEAL domains in
the asymmetric unit could mediate the formation of
higher-order structures involving more than one EAL
domain in solution. However, in SEC analyses,
FimXEAL continues migrating as a monomer in the
presence of Ca2+ (data not shown). Furthermore,
the concentration-dependent shifts in elution vol-
umes observed for the PilZ–FimXEAL and PilZ–
FimXEAL(436–689) complexes were the same in the
presence of 1 mM Ca2+ (data not shown). Finally,
the presence of Ca2+ did not increase the confor-
mational stability of FimXEAL or FimXEAL(436–689) or
their complexes with PilZ in thermal denaturation
experiments monitored by circular dichroism (data
not shown). These observations suggest that the
Ca2+-mediated heterodimer–heterodimer contacts
observed in the crystal are not stable in solution
under the in vitro conditions tested.
Discussion
A rare syn conformation for the bound c-di-GMP
ligand
In all protein–c-di-GMP and riboswitch–c-di-GMP
complexes, as well as in small molecule crystals of c-
di-GMP, the two glycosidic bonds are found in the
anti conformation. It was therefore initially surprising
to observe the syn conformation of one of the two
glycosidic bonds of the c-di-GMP ligand in both
FimXEAL–c-di-GMP and PilZ–FimXEAL–c-di-GMP
structures reported here and in the FimXEAL–c-di-
GMP structure from Xcc strain 17.56 However, when
we consider the fact that c-di-GMP on its own is
structurally polymorphic, it should not come as a
surprise that these degrees of freedom would be
reflected in its protein–ligand complexes. Theoretical
calculations suggest that the ground state of c-di-GMP in water is a “closed” conformer in which the
two guanines are parallel and separated by 6.8 Å
while the “open” conformer, in which the inter-
guanine distance is 13.5 Å, is only slightly less
stable (1.9 kcal/mol).66 In both these closed and
open structures, the two glycosidic bonds are anti.
The energetics of the anti-to-syn transition in
monomeric c-di-GMP has not to our knowledge
been simulated; however, theoretical calculations of
this transition for guanosine in nucleic acids suggest
a low energy barrier.69,70 Therefore, monomeric c-
di-GMP in solution probably exists as a continuum of
conformers that populate a wide range of inter-
guanine distances and glycosidic torsion angles and
sugar-phosphate macrocycle conformations. Fur-
thermore, in solution, there is a dynamic equilibrium
between oligomeric forms that can oscillate between
syn and anti conformers in a manner that is
extremely sensitive to monovalent metal ions.65–68
Protein-bound c-di-GMP has been observed both in
the anti/anti open form as a monomer bound to
EAL12,13,62,64 and GGDEF domains80 and in the
closed anti/anti forms as a monomer bound to a PilZ
domain 51 and intercalated dimers bound to
GGDEF74,75,80,81 and PilZ domains.76,82 A mono-
meric anti/anti closed form has also been found
bound to a riboswitch RNA where it is stabilized via
intercalations with an RNA base.77 The syn confor-
mation of purine nucleotides has been observed in
the high-resolution structures of RNA molecules83
and RNA–protein complexes,84 anti-to-syn confor-
mational transitions occur between B- and Z-DNA85
and an anti-to-syn conformational switch in the
template DNA has been observed to confer a
purine-specific bias for a eukaryotic DNA polymer-
ase ι. 86 Therefore, anti-to-syn conformational
changes could be coupled to protein conformational
states important for regulation of other important
cellular processes.
Comparison of the Xac and Xcc strain 17
PilZ–FimXEAL–c-di-GMP structures
During the preparation of this manuscript, Chin et
al. reported the structures of the FimXEAL–c-di-GMP
and PilZ–FimXEAL–c-di-GMP complexes from Xcc
strain 17.56 In that work, they also observed a syn/
anti c-di-GMP conformation in the FimXEAL–c-di-
GMP structure. A superposition of the Xac and Xcc
strain 17 FimXEAL–c-di-GMP structures reveals that
they are very similar (r.m.s.d. = 0.90 Å for Cα atoms
of the TIM barrel). However, the structure of the Xcc
strain 17 PilZ–FimXEAL–c-di-GMP complex
56 has
some important differences with respect to the Xac
PilZ–FimXEAL–c-di-GMP complex reported here and
are analyzed below.
One striking difference between the Xac and Xcc
strain 17 structures is the orientation of the FimXEAL
α1 helices (Fig. 8). In the Xac PilZ–FimXEAL–c-di-
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similar to that observed in the absence of PilZ
(Supplementary Fig. 10). In the Xcc strain 17 PilZ–
FimXEAL–c-di-GMP structure, the α1 helix goes in
the opposite direction (Fig. 8), exchanging positions
with its symmetry-related partner on the opposite
side of a 2-fold crystallographic axis.56 This swap-
ping of helices increases the interaction between the
two FimXEAL domains and stabilizes a tetrameric
quaternary structure in which the PilZ and FimXEAL
pairs are related by a 2-fold symmetry axis.56
Evidence for the tetrameric structure for the Xcc
strain 17 complex in solution was obtained from SEC
analysis.56 In contrast, we do not have evidence that
the Xac PilZ–FimXEAL–c-di-GMP complex can form
a stable tetramer in solution and the relative
orientations of the FimXEAL subunits in the crystal
would not permit the helix swapping observed in the
Xcc strain 17 structure. As mentioned above, the
FimXEAL constructs used in the Xac and Xcc strain
17 PilZ–FimXEAL–c-di-GMP complexes differ by 10
N-terminal amino acids (residues 426–436) present
in the Xac construct and absent in the Xcc strain 17N
C C
α1
α1
N
Fig. 8. Comparison of the Xac and Xcc strain 17 PilZ–
FimXEAL–c-di-GMP structures. Superposition of the PilZ–
FimXEAL–c-di-GMP structures from Xac (colored green
and red for FimXEAL and yellow for PilZ) and Xcc strain
1756 (colored blue for FimXEAL and orange for PilZ). Only
one heterodimer of the tetrameric Xcc strain 17 PilZ–
FimXEAL–c-di-GMP structure is shown. Residues 426–436
at the N-terminus and residues 685–689 at the C-terminus
of the Xac structure are shown in red and are absent in the
Xcc strain 17 FimXEAL construct. The c-di-GMP ligands
(red for the Xac structure and blue for Xcc strain 17) are
shown as stick models. The superposition was guided by
structurally aligning the TIM barrel domains of the FimXEAL
subunits (residues 460–480 and 504–684; Xac
numbering).protein (Fig. 8). The interactions between PilZ and
FimXEAL residues 426–435 [absent in the Xac PilZ–
FimXEAL(436–689) and Xcc strain 17 PilZ–FimXEAL
complexes] would be expected to stabilize the
heterodimeric form of the complex with respect to
the helix-swapped tetrameric form. We did in fact
observe that the Xac PilZ–FimXEAL(436–689) complex
migrates in SEC column with an apparent molecular
weight greater than the apparent molecular weight
observed for PilZ–FimXEAL (instead of the expected
decrease due to its slightly smaller size). While the
apparent molecular weight is still more consistent
with that of a PilZ–FimXEAL(436–689) heterodimer than
a tetramer, a fast equilibrium between a stable
heterodimer and a transient tetrameric species could
explain the concentration dependence of the appar-
ent molecular weight of the complex calculated by
SEC.
Another interesting difference is that Chin et al.
reported that no Xcc strain 17 PilZ–FimXEAL complex
could be observed in the absence of c-di-GMP.56
This contrasts our observations of complex forma-
tion in both the absence and the presence of c-di-
GMP when using either FimXEAL or FimXEAL(436–689)
constructs. Our results for the Xac complex were
recently corroborated independently by the group of
Qi et al.78 who measured highly similar dissociation
constants for the Xac PilZ–FimXEAL(436–689) complex
in the absence and presence of c-di-GMP. Differ-
ences in the crystallization conditions (presence
versus absence of Ca2+) and crystal packing in the
alternate space groups (P65 versus P6322) could go
a long way to explain the significant differences in
the crystal structures observed. However, they do
not satisfactorily explain the differences in their
quaternary structures in solution and the differences
in their dependences on c-di-GMP for the PilZ–
FimXEAL interaction. They should ultimately be
explainable by the small differences in the se-
quences of the proteins from the two Xanthomonas
species.
While the FimX EAL domains from Xac and Xcc
strain 17 are very similar, with only nine differences
in their sequences between residues 436 and 684
(Xac numbering56,87), one of these differences (Val
versus Ile) is at position 454, precisely in the loop
between α1 and β1 where the paths of the main
chains in the two proteins begin to diverge. Also,
there are significant differences between the
FimXEAL constructs used for crystallization that may
explain the differences in the structures observed.
Firstly, the FimXEAL domain used in the present study
is 10 amino acids longer at its N-terminus than that
used by Chin et al.56 These extra residues (426–
435) take part in significant interactions with PilZ in
our structure (Figs. 4a, 5c and 8 and Supplementary
Fig. 10). Their absence in the Xcc strain 17 complex
could explain the drastically different orientation and
swapping of the α1 helix. Secondly, the C-terminal
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dues 685–689 of Xac FimX are NYEFG while the
Xcc strain 17 FimXEAL construct lacks these
residues.56,87 The aromatic side chains from
Tyr686 and Phe688 of this motif make several
hydrophobic van der Waals contacts with Pro464,
Leu466, Pro472, Glu474, Tyr476 and Ala678 (Sup-
plementary Fig. 13a). It is important to note that
these contact residues are flanked by residues that
interact directly with the c-di-GMP ligand (Gln463,
Ala478, Phe479, Leu480, Arg481; Fig. 2b and
Supplementary Fig. 13b).
Another significant difference between the Xac
and Xcc strain 17 structures is the relative position of
the PilZ domain with respect to the FimXEAL TIM
barrel domains. Figure 8 and Supplementary Fig. 14
show that when the FimXEAL TIM barrel domains are
used to align the Xac and Xcc PilZ–FimXEAL–c-di-
GMP heterodimers, the PilZ β5, β6 and β3 strands
adopt very similar positions since they take part in β-
sheet extension with the FimXEAL domain. However,
large differences are observed in the positions of the
remaining PilZ secondary structure elements (Fig. 8
and Supplementary Fig. 14). For example, the C-
termini of the Xcc strain 17 β1 and β4 strands
superpose most closely with the Xac β4 strand and
β5 strand N-terminus, respectively (Supplementary
Fig. 14b). With respect to the Xac PilZ domain, the
r.m.s.d. positional shift of the Xcc strain 17 PilZ main-
chain atoms is 3.3 or 4.0 Å, depending on which Xac
PilZ–FimXEAL–c-di-GMP heterodimer is used in the
alignment (a value greater than the 2.6 Å relative
shifts in PilZ positions in the two Xac PilZ–FimXEAL–
c-di-GMP heterodimers).
Even though the Xac and Xcc strain 17 PilZ
sequences are different at only three positions
(Pro19, Gly31 and Ile68 in Xac; Ala19, Ser31 and
Val68 in Xcc strain 17), all three positions are located
at or near the PilZ–FimXEAL interface (Figs. 4 and 5
and Supplementary Table 2). (i) In the Xac structure,
Pro19 makes contacts with Tyr429 of FimXEAL, an
interaction absent in the Xcc strain 17 FimXEAL
construct that begins at residue 436. (ii) PilZ position
31 immediately follows lysine 30 whose side chain
makes direct contacts with FimXEAL Glu499 in Xac
but that contacts the c-di-GMP ligand in Xcc strain
17. An increase in the flexibility in this region due to
glycine at position 31 in Xac could increase the
entropic penalty associated with the interaction
between the neighboring Lys30 side chain and c-
di-GMP. (iii) As mentioned above, PilZ Ile68 interacts
with FimXEAL Ala493 (Fig. 5a). In fact, the Ile68 C
δ
methyl group makes van der Waals contacts with the
Cβ methyl of Ala493 in the FimXEAL α2 helix that
simultaneously contacts PilZ and the c-di-GMP
ligand. The conformational flexibility of the α2 helix
may be important for the interaction with c-di-GMP
(Fig. 1d).12 In Xcc strain 17 PilZ, position 68 is
occupied by a valine, which lacks a Cδ methyl group;thus, these PilZ–FimX interactions could be signif-
icantly modified. Furthermore, the carbonyl oxygen
of the peptide bond between Val67 and Il68 interacts
with the phosphate group of c-di-GMP via a water
bridge (Fig. 5d). The above considerations point to
how only a few differences between otherwise highly
conserved FimXEAL and PilZ proteins could change
the nature of their interactions with FimXEAL and
possibly with the c-di-GMP ligand.
Another important difference between the Xac and
Xcc strain 17 structures is the conformation of the c-
di-GMP ligand: syn/anti in the Xac complex and all-
anti in the Xcc strain 17 complex (Supplementary
Fig. 15). These differences are intriguing and could
be related to differences in the FimXEAL–PilZ
contacts observed in the two structures discussed
above. However, before attempting to identify the
reasons behind these different c-di-GMP conforma-
tions, we should first look at the experimental
evidence that supports both of them. As mentioned
previously, the 2Fo − Fc and omit maps of the c-di-
GMP binding site in the 2.1-Å Xac PilZ–FimXEAL–c-
di-GMP structure reported here supports the refined
syn/anti conformation of the c-di-GMP ligand (Sup-
plementary Fig. 7). However, in the 3.0-Å Xcc strain
17 PilZ–FimXEAL–c-di-GMP structure, the coordi-
nates of the atoms of the c-di-GMP ligand are
modeled with an occupancy of 0.5 (PDB code
4F4856). Supplementary Figure 16a shows that
when we use the deposited structure factors and
Xcc strain 17 PilZ–FimXEAL–c-di-GMP model to
calculate the electron density, the 2Fo − Fc map
contoured at 1.0 σ does not present electron density
at most of the atomic positions of the c-di-GMP
ligand. When the contour level is reduced to 0.5 σ,
some density does appear (Supplementary Fig.
16b). In order to determine whether this density is
the result of model bias, we recalculated the map
using the Xcc strain 17 PilZ–FimXEAL–c-di-GMP
complex in which the c-di-GMP coordinates were
omitted. The 2Fo − Fc omit map contoured at 1.0 σ
and 0.5 σ (Supplementary Fig. 16c and d) and the
Fo − Fc omit map contoured at 3 σ and 2 σ
(Supplementary Fig. 16e and f) show no evidence
for any significant electron density in the c-di-GMP
binding site. The above observations lead us to the
opinion that the conformation of the c-di-GMP ligand
in the Xcc strain 17 PilZ–FimXEAL–c-di-GMP struc-
ture is not supported by the experimental data and
that conclusions regarding specific details of the
ligand–protein interactions in that structure are
unwarranted.
Interpretation of the PilZ–FimXEAL–c-di-GMP
structure in the context of regulatory models of
type IV pilus biogenesis
Recent models of the incorporation or removal of
pilin subunits at the base of the T4P implicate actions
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respectively.37,41,88 Both PilZ and FimX were initially
characterized in P. aeruginosa where they regulate
type IV pilus biogenesis through unknown mecha-
nisms, though our group has shown that PilZ can
interact with both the FimX EAL domain and with
PilB. All three of these proteins are required for the
appearance of pili subunits on the bacterial surface
and for twitching motility in P. aeruginosa.45,47,49
Small-angle X-ray analysis of P. aeruginosa FimX
indicates that it is a dimer in solution and that
dimerization is mediated via interactions between its
N-terminal REC domains.12 Recently, Qi et al.
provided structural evidence for long-range c-di-
GMP-mediated communication between the EAL
domain and the N-terminal region of P. aeruginosa
FimX.79 They used mass spectrometry to show that
c-di-GMP binding reduces the 1H/2H exchange
rates not only of peptides derived from the EAL
domain but also of a peptide derived from the REC
domain and a second peptide derived from an
adjacent linker region between the REC and PAS
domains. No significant changes in 1H/2H exchange
rates were observed for peptides derived from the
intervening PAS and GGDEF domains.79 Their
results may explain why both the N-terminal REC
domain and c-di-GMP binding to the EAL domain
seem to be necessary for the unipolar localization of
FimX in P. aeruginosa.48,49 Jain et al. recently
showed that FimX is required for T4P formation at
low c-di-GMP levels but that this requirement is
circumvented at elevated c-di-GMP levels.89 How-
ever, PilZ is not required for the polar localization of
FimX in P. aeruginosa49 and while FimX and PilZ
homologs in Xac24,78 and Xcc stain 1756 bind to one
another, attempts to observe this interaction be-
tween the P. aeruginosa proteins have failed,
apparently due to the significant differences between
Pseudomonas and Xanthomonas FimX proteins
(29% sequence identity for their EAL domains).78
Therefore, one should be careful to extrapolate
conclusions from studies in Pseudomonas to other
species. Future work will determine whether FimX
and/or PilZ localize to the bacterial poles and the
means by which c-di-GMP contributes to these
control processes in Xanthomonas species.
The X. citri genome90 codes for 3 proteins with
EAL domains, 20 proteins with GGDEF domains and
11 more (including FimX) with both GGDEF and EAL
domains; in all the latter cases, the GGDEF domain
precedes the EAL domain.23 GGDEF-EAL modules
are highly ubiquitous in bacterial genomes. For
example, there are over 8000 in the Pfam database
at the moment.50 In spite of their ubiquity, the only
structure of a GGDEF-EAL module is that of LapD,
crystallized in the absence of c-di-GMP. In the apo-
LapDGGDEF-EAL structure, the principal contact be-
tween the two domains is where a loop on the
surface of the GGDEF domain formed by LapDresidues 259–263 occludes the c-di-GMP binding
site of the EAL domain.13 What appears to maintain
their relative orientations in the crystal are contacts
of the EAL domain and the so-called S-helix that
links the N-terminus of the LapD GGDEF domain to
the HAMP domain that precedes it.13 In FimX, the S-
helix would correspond to the linker between the
PAS and GGDEF domains. Interestingly, the S-helix
in LapD interacts with EAL domain residues that are
found in the most highly conserved positions
(outside of the c-di-GMP binding site) within the
EAL domains of proteins that share the REC-PAS-
GGDEF-EAL domain topology of FimX (Supplemen-
tary Fig. 3). A superposition of the EAL domains in the
PilZ–FimXEAL–c-di-GMP and apo-LapDGGDEF-EAL
structures indicates that PilZ binding to FimX would
not permit its EAL and GGDEF domains to interact in a
manner similar to that observed in apo-LapDGGDEF-EAL
due to bad steric contacts (Fig. 9a). Another
interesting point is that PilZ interacts with the N-
terminal helix of the EAL domain of FimX that can be
considered part of a linker that joins the EAL to the
preceding GGDEF domain. Therefore, binding of
PilZ to FimX would be expected to modulate the
relative orientation between the EAL and GGDEF
domains both by blocking part of the binding site
between the two domains and by controlling the
possible conformations of the linker that binds the
two domains.
The above considerations point to a model
(Fig. 9b) by which c-di-GMP binding to the FimX
EAL domain can modulate its interactions with the
GGDEF domain and with PilZ. If c-di-GMP binding
favors an open conformation of the FimX GGDEF-
EAL module (by directly competing for an over-
lapping binding site as is the case for LapD13), this
would have the indirect effect of increasing the
affinity of the EAL domain for PilZ. Other signals that
are sensed by the REC and PAS domains of FimX
could be transmitted via the PAS-GGDEF linker (S-
helix in Fig. 9b) to regulate the conformation of the
FimX GGDEF-EAL module. In this way, c-di-GMP
and other signals could be integrated in a manner
that modulates the interaction between PilZ and
PilB, in some way regulating the latter's ATPase and
pilus polymerization activity at the base of the type IV
pilus. The PilZ–PilB interaction requires a well-
conserved C-terminal motif V (SXXXTXT) that is
disordered and lacking electron density in both the
PilZ stand-alone structure24 and the PilZ–FimXEAL–
c-di-GMP complex. This sequence extends from the
PilZ C-terminal helix (α2) that accompanies the
FimXEAL N-terminal helix (α1) in an antiparallel
fashion and is not required for interactions with
FimX.24
It is becoming evident that many c-di-GMP-
mediated signaling pathways involve interactions
between proteins with GGDEF, EAL, HD-GYP and
PilZ domains.23–26 In addition to the FimX–PilZ–PilB
Fig. 9. (a) Structural alignment of the PilZ–FimXEAL–c-di-GMP complex and the apo-LapDEAL-GGDEF structures.
Cartoon representations of PilZ (yellow), the FimXEAL TIM barrel (green) and lobe (dark blue) regions and the EAL
(cyan) and GGDEF (salmon) domains and the S-helix (orange) of apo-LapDEAL-GGDEF
13 are shown. C-di-GMP bound
to the FimXEAL domain is shown as a red stick model. The structural alignment was guided by the superposition of the
TIM barrel regions of the FimX and LapD EAL domains (residues 460–480 and 504–689; numbering from Xac FimX
protein). Note the structural overlap of the PilZ α2 helix and the GGDEF α4 helix. (b) Proposed model for the coupling
of the possible conformational states of the GGDEF-EAL module in FimX to the binding of PilZ and c-di-GMP. Top line:
In the absence of PilZ and c-di-GMP, the GGDEF-EAL module can adopt a closed structure similar to that observed for
apo-LapDGGDEF-EAL
13 in which GGDEF-EAL interactions are stabilized by binding of the S-helix to the EAL TIM barrel
(top left). In LapDGGDEF-EAL, this conformation is not compatible with c-di-GMP binding due to steric overlap of the
ligand binding site with a loop on the surface of the GGDEF domain formed by LapD residues 259–263.13 Since the
GGDEF-EAL modules of Xac FimX and P. fluorescens LapD share only 25% and 39% sequence identity and
similarity, respectively, it is not clear whether this closed conformational state of FimX could bind c-di-GMP (indicated
by a transparent representation of the complex on the top right). Middle and bottom lines: The GGDEF and EAL
domains can dissociate to produce an open structure that is able to bind both c-di-GMP (red star) and PilZ. The color
scheme is similar to that in (a).
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interactions in X. campestris pv campestris strain
8004 have been observed to occur involving the c-di-
GMP-specific PDE RpfG, two GGDEF proteins
(XC_0249 and XC_0420), a PilZ domain protein
(XC_2249) and the two type IV pilus ATPases PilT
and PilU.26 Like PilB, PilU and PilT are hexameric
ATPases that function as pilus motor proteins. While
PilB is required for pilus polymerization/extension,
PilU and PilT are required for pilus depolymerization/
retraction.38,44 This suggests that the interactions of
these ATPases with other T4P components may be
regulated by a complex set of protein–proteininteractions that may be modulated by c-di-GMP
and/or other metabolic or environmental signals as
shown in Fig. 10. At a general level, the scheme
shown in Fig. 10 is intriguingly similar to the recently
elucidated protein–protein interaction network in
which the physical interaction of a PilZ domain c-
di-GMP receptor protein with components at the
base of the bacterial flagellum controls swimming
motility in E. coli and Salmonella.29,30,34 Therefore,
protein–protein interaction networks involving c-di-
GMP signaling domains interfacing with supramo-
lecular nanomachines in biological systems are
emerging as a new paradigm.
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Cloning, protein expression and purification
PilZXAC1133; the PilZ mutants PilZY22A, PilZF28A, PilZ-
W69A and PilZE101A; and the FimX fragment corresponding
to residues 436–689 [FimXEAL(436–689)] were expressed
and purified as described previously.24,91 The coding
sequence for a new construct of the FimX EAL domain
(FimXEAL) corresponding to residues 426–689 was ampli-
fied by PCR from Xac genomic DNA90 using the primers 5′
CGGTGGCCATATGGTCAGCATCTACGATCCGGCT 3′
and 5 ′ TTGGATCCTCAGAAATCGCCCTGGACG-
TAGTCC 3′ and cloned into the expression vector
pET3a92 in the NdeI and BamHI sites. All clones were
confirmed by DNA sequencing. Site-directed mutagenesis
of the FimXEAL(426–689) domain in the pET3a vector was
used to produce the FimXEAL A493N and R534A mutants
via a single-step PCR protocol using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene). To produce the
FimXEAL A493N mutant, we used the following primers:
forward 5′ GAAATGATGTCGCCGAACAATTTCATGGC-ADP  ATP
Polymerization/
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Fig. 10. Protein–protein interaction networks involving c-di-
type IV pilus. Pilus polymerization/extension is dependent on
components (including PilC), works to incorporate pilin subuni
shown) are hexameric ATPases that function as pilus motor p
retraction.38,44 The pilus passes through the outer membran
subunits.57 The means by which these processes are regulate
such as PilZ and FimX have been identified.47,49 As well as b
interactions in X. campestris pv campestris strain 8004 have b
RpfC, the c-di-GMP-specific PDE RpfG, two GGDEF protein
(shown) and PilU (not shown).26 This suggests that the interac
regulated by a complex set of protein–protein interactions that
environmental signals. Abbreviations: A, PilA; B, PilB; C, PilC; Q
model and does not include all of the proteins implicated in T4CATTGCCGAAGA 3′ and reverse 5′ TCTTCGGCAATG-
GCCATGAAATTGTTCGGCGACATCATTTC 3′. To
produce the FimXEAL R534Amutant, we used the following
primers: 5′ ACAAGACCCACCTGCTGGTTGCCATCG-
GACCGAACTCGTTCT 3′ and reverse 5′ AGAACGAG-
TTCGGTCCGATGGCAACCAGCAGGTGGGTCTTGT 3′.
FimXEAL, FimXEAL_A493N and FimXEAL_R534A were
expressed in E. coli strain BL21(DE3)pLysS.92 The cells
were grown in 2× TY medium (16 g/L of bacto-tryptone,
10 g/L of yeast extract and 5 g/L of sodium chloride)
supplemented with ampicillin (100 mg/mL) under agitation
of 200 r.p.m. at 37 °C to an OD600 of 0.8, at which point
0.4 mM isopropyl-β-D-1-thiogalactopyranoside was
added. After 4 h of induction, the cells were collected
and stored at 193 K. Cells from a 1-L culture were
resuspended in 25 mL of lysis buffer [50 mM Tris–HCl
(pH 7.0), 25% sucrose and 1 mM ethylenediaminetetraa-
cetic acid] and lysed by sonication. The lysate was
centrifuged at 17,500g, 4 °C for 45 min. The soluble
fraction was applied to a Q-Sepharose Fast Flow HiLoad
16/10 column (GE Healthcare) previously equilibrated with
50 mM Tris–HCl (pH 7.5), 14 mM 2-mercaptoethanol and
1 mM ethylenediaminetetraacetic acid. Bound proteinsT
TP
merization/
ion
RpfG
RpfC
DSF
other
signals
A
2 G c-MP di-GMP
c-di-GMP 2GTP
Z* GGDEF
protein
GMP signaling domains at the base of the Xanthomonas
the hexameric ATPase PilB, which, along with other T4P
ts (PilA) at the pilus base.38,45 Like PilB, PilT and PilU (not
roteins, but in this case driving pilus depolymerization and
e though a pore made up of a dodecameric ring of PilQ
d are largely unknown, but some regulators of the process
inding to FimX, PilZ also binds to PilB.24 A parallel set of
een observed to occur involving the DSF receptor protein
s, a PilZ domain protein (Z*) and the two ATPases PilT
tions of these ATPases with other T4P components maybe
may be modulated by c-di-GMP and/or other metabolic or
, PilQ; T, PilT; Z, PilZ; Z*, PilZ homolog. This is a simplified
P assembly and regulation.
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column volumes. The fractions containing FimXEAL,
FimXEAL_A493N and FimXEAL_R534A were pooled and
concentrated using Centricon (Millipore) concentrator with
a 10-kDa membrane cutoff and applied onto a Superdex
200 26/60 size-exclusion column (GE Healthcare) previ-
ously equilibrated with 10 mM Tris (pH 7.0), 20 mM NaCl,
10 mM MgCl2 and 1 mM 2-mercaptoethanol. The fractions
containing FimXEAL and the mutants were pooled and
concentrated to 5–10 g/L using Centricon (Millipore) con-
centrators with a 10-kDa membrane cutoff.Crystallization of the FimXEAL(426–689) domain in
complex with c-di-GMP and the PilZ–FimXEAL–c-di-
GMP complex
Initial crystallization conditions for FimXEAL(426–689) and
PilZXAC1133–FimXEAL in complex with c-di-GMP crystals
were obtained using the Crystal Screen (Hampton
Research), Index Screen (Hampton Research), Nextal
PegII Suite and Nextal ProComplex Suite (Qiagen)
matrices. Initial crystallization conditions were optimized
by varying the concentration of the precipitating reagent,
the buffer pH and the temperature. FimXEAL–c-di-GMP
crystals were obtained by mixing equal volumes (1.5 μL) of
protein [6.2 g/L protein containing 375 μM c-di-GMP
(Biolog, Germany)] and reservoir solution consisting of
0.6 M ammonium sulfate and 0.1 M sodium citrate
(pH 4.7). Better-diffracting crystals were obtained using
the same conditions except that the protein solution also
contained 500 μM calcium chloride. The PilZ–FimXEAL
complex used in crystallization assays was obtained
mixing pure samples of FimXEAL and PilZ and applying
this mixture to the Superdex 200 26/60 size-exclusion
column (GE Healthcare) previously equilibrated with
10 mM Tris–HCl (pH 8.0), 5 mM NaCl, 2 mM MgCl2 and
2 mM CaCl2. Eluted fractions containing both proteins
were pooled and concentrated to 120 μM using Centricon
(Millipore) concentrators with a 3-kDa membrane cutoff.
The best crystallization condition for the PilZ–FimXEAL–c-
di-GMP complex was obtained using equivalent volumes
(1.5 μL) of the protein complex (120 μM PilZ–FimX–EAL
plus 150 μM c-di-GMP) and reservoir solution consisting of
18% polyethylene glycol 4000, 0.1 M Tris (pH 7.5) and
0.2 M CaCl2. All crystals were obtained by sitting-drop
vapor diffusion technique and grew to maximum size in
approximately 3–14 days at 18 °C.Structure determination and refinement
X-ray diffraction data for the FimXEAL–c-di-GMP com-
plex in the presence of calcium chloride and the PilZ–
FimXEAL–c-di-GMP complex crystals were collected on the
W01B-MX2 beamline at the Laboratório Nacional de Luz
Sincrotron, Campinas, São Paulo, using a MARMosaic
225 CCD detector. Diffraction data for the FimXEAL–c-di-
GMP crystal were collected on theW01B-MX1 beamline of
the Laboratório Nacional de Luz Sincrotron using a MAR
CCD detector. Crystals were flash-frozen and maintained
at 100 K in a stream of cold nitrogen gas during
measurement. Diffraction intensities for the data sets
were indexed, integrated and scaled using the programs
DENZO and SCALEPACK from the HKL2000 package(Otwinowski and Minor, 1997). Crystallographic data
statistics are shown in Table 1. There is one FimXEAL–c-
di-GMP complex per asymmetric unit (Matthews coeffi-
cient VM = 2.22 Å
3/Da and the estimated solvent content
is 44.55%) and two heterodimers of PilZ–FimXEAL–c-di-
GMP complex per asymmetric unit (Matthews coefficient
VM = 2.95 Å
3/Da and the estimated solvent content is
58.39%). The initial phases for the FimXEAL–c-di-GMP
complex were solved by molecular replacement using
Phaser93 using the main chain of the FimX EAL domain
from P. aeruginosa (PDB ID 3HV8; Ref. 12) as a model.
The initial phases of the PilZ–FimXEAL–c-di-GMP complex
were obtained by molecular replacement using the Xac
FimXEAL (this work) and the Xac PilZ structures (PDB ID
3CNR; Ref. 24) as models. Structural refinement of the
models was performed using CCP4i,94 REFMAC95 and
Coot.96 Water molecules were added automatically using
REFMAC and manually using Coot. Details of the
refinement data statistics are shown in Table 1. The
coordinates of final models have been deposited in the
PDB and the accession codes are shown in Table 1.
Structural alignments and figures were produced using
PyMOL.97
SEC analysis
A Superdex™ 75 HR 10/30 (GE Healthcare) column
was calibrated with the protein mixture from the Gel
Filtration Calibration Kit MW (SIGMA Life Science) as
described in the legend to Fig. 7. The buffer used for
column calibration and protein elution was 50 mM Tris
(pH 8.0), 20 mM MgCl2, 50 mM NaCl, 1 mM ethylene
glycol bis(β-aminoethyl ether) N,N,N′,N′-tetraacetic acid
and 14 mM 2-mercaptoethanol and the flow rate was
0.5 mL/min. Concentrated samples (15 μL) of PilZ, FimX-
EAL, their mutants and their complexes were applied to the
SEC column. Where indicated, c-di-GMP (150 μM) was
also applied to the sample. FimXEAL and FimXEAL mutant
concentrations varied from 40 to 80 μM and a 2-fold molar
excess of PilZ was added.
NMR spectroscopy
Watergate STE-DOSY experiments were recorded in a
Bruker AvanceIII Spectrometer operating at 500 MHz 1H
field using a translational diffusion delay of 500 ms
[FimXEAL(426–689)] or 600 ms [FimXEAL(426–689))–PilZ]. A
total of 16 gradient strength increments were collected in
the indirect dimension. The translational diffusion coeffi-
cient was obtained by nonlinear fitting of the diffusion
decay profiles to an exponential decay function as
previously described.98
Protein stability studies
Thermal unfolding of FimXEAL and its mutants was
followed by measuring [θ]220 nm as the temperature was
increased at a rate of 1 °C/min. Samples were prepared
using 10 μM protein, 20 mM Tris–Cl (pH 8.0), 10 mM
NaCl, 0.5 mM ethylene glycol bis(β-aminoethyl ether) N,N,
N′,N′-tetraacetic acid and 5 mM MgCl2 in a 1-mm-quartz
cuvette. Where indicated, 50 μM c-di-GMP was added.
The fraction of unfolded protein was calculated by using the
2194 Structure of the PilZ–FimXEAL–c-di-GMP Complexpre-transition and post-transition baselines to calculate the
fractional change in signal at each temperature point as
previously described.99
Accession numbers
The atomic coordinates and structure factors of the
structures reported in this work have been deposited in the
PDB with the following accession numbers: PDB IDs
4FOJ, 4FOK and 4FOU (see Table 1).Acknowledgements
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